597 related articles for article (PubMed ID: 10753983)
1. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Lip GY
Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
[TBL] [Abstract][Full Text] [Related]
2. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
Kamath S; Blann AD; Chin BS; Lip GY
J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
[TBL] [Abstract][Full Text] [Related]
3. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.
Lip GY; Lip PL; Zarifis J; Watson RD; Bareford D; Lowe GD; Beevers DG
Circulation; 1996 Aug; 94(3):425-31. PubMed ID: 8759084
[TBL] [Abstract][Full Text] [Related]
4. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
Lip GY; Lowe GD; Rumley A; Dunn FG
Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
[TBL] [Abstract][Full Text] [Related]
5. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.
Kamath S; Blann AD; Chin BS; Lanza F; Aleil B; Cazenave JP; Lip GY
Eur Heart J; 2002 Nov; 23(22):1788-95. PubMed ID: 12419299
[TBL] [Abstract][Full Text] [Related]
6. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
Lancet; 1996 Sep; 348(9028):633-8. PubMed ID: 8782752
[TBL] [Abstract][Full Text] [Related]
7. Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).
Ezekowitz MD; Reilly PA; Nehmiz G; Simmers TA; Nagarakanti R; Parcham-Azad K; Pedersen KE; Lionetti DA; Stangier J; Wallentin L
Am J Cardiol; 2007 Nov; 100(9):1419-26. PubMed ID: 17950801
[TBL] [Abstract][Full Text] [Related]
8. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: effects of cardioversion to sinus rhythm.
Lip GY; Rumley A; Dunn FG; Lowe GD
Int J Cardiol; 1995 Oct; 51(3):245-51. PubMed ID: 8586473
[TBL] [Abstract][Full Text] [Related]
9. Effects of fixed low-dose warfarin on hemostatic factors in continuous ambulatory peritoneal dialysis patients.
Kim SB; Lee SK; Park JS; Chi HS; Hong CD; Yang WS
Am J Kidney Dis; 2001 Feb; 37(2):343-7. PubMed ID: 11157376
[TBL] [Abstract][Full Text] [Related]
10. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation.
Nozawa T; Inoue H; Iwasa A; Okumura K; Jong-dae L; Shimizu A; Hayano M; Yano K
Circ J; 2004 Jan; 68(1):29-34. PubMed ID: 14695462
[TBL] [Abstract][Full Text] [Related]
11. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
[TBL] [Abstract][Full Text] [Related]
12. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
Gulløv AL; Koefoed BG; Petersen P
Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
[TBL] [Abstract][Full Text] [Related]
13. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.
Gulløv AL; Koefoed BG; Petersen P; Pedersen TS; Andersen ED; Godtfredsen J; Boysen G
Arch Intern Med; 1998 Jul; 158(14):1513-21. PubMed ID: 9679792
[TBL] [Abstract][Full Text] [Related]
14. Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy.
Blackshear JL; Baker VS; Holland A; Litin SC; Ahlquist DA; Hart RG; Ellefson R; Koehler J
Arch Intern Med; 1996 Mar; 156(6):658-60. PubMed ID: 8629878
[TBL] [Abstract][Full Text] [Related]
15. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
Marín F; Roldán V; Climent VE; Ibáñez A; García A; Marco P; Sogorb F; Lip GY
Heart; 2004 Oct; 90(10):1162-6. PubMed ID: 15367514
[TBL] [Abstract][Full Text] [Related]
16. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
Lip GY; Blann AD; Jones AF; Lip PL; Beevers DG
Am J Cardiol; 1997 Dec; 80(12):1566-71. PubMed ID: 9416937
[TBL] [Abstract][Full Text] [Related]
17. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Edmunds E; Gibbs CR; Lip GY
Clin Cardiol; 2001 May; 24(5):409-14. PubMed ID: 11346250
[TBL] [Abstract][Full Text] [Related]
18. Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients.
Yashiro Y; Arimoto T; Hashimoto N; Tamura H; Iwayama T; Ishigaki D; Kumagai Y; Nishiyama S; Takahashi H; Shishido T; Miyamoto T; Watanabe T; Kubota I
Circ J; 2015; 79(1):61-9. PubMed ID: 25391906
[TBL] [Abstract][Full Text] [Related]
19. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
Jia XQ; Dong CM; Qin J; Zhang L
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576
[TBL] [Abstract][Full Text] [Related]
20. Warfarin in atrial fibrillation patients with moderate chronic kidney disease.
Hart RG; Pearce LA; Asinger RW; Herzog CA
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2599-604. PubMed ID: 21903982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
